Marc Spielmann

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials.

R. Arriagada, S. Michiels, F. André, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes.

R. Arriagada, M. Tubiana, M. Spielmann, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma

L. Zelek, A. Le Cesne, M. Spielmann, 2001, Cancer.

Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers

L. Zelek, M. Mathieu, M. Kaghad, 2000, Oncogene.

A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

L. Zelek, M. Spielmann, E. Brain, 2006, British Journal of Cancer.

Risk factors for brain relapse in patients with metastatic breast cancer.

F. André, A. Dunant, M. Spielmann, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.

M. Namer, J. Bonneterre, J. Zalcberg, 1996, British Journal of Cancer.